Melanoma: Genomic Profiles, Molecular Markers and Therapeutic Implications
NCT05119829 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 80
Last updated 2022-03-31
Summary
The goal of this study is to evaluate the genomic profiles and investigate the prevalence of germ line and pathogenic mutations in Greek population with early and metastatic melanoma and their correlation with the treatment and prognosis of the disease.
Conditions
Sponsors & Collaborators
-
Hellenic Cooperative Oncology Group
lead OTHER
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 1998-02-01
- Primary Completion
- 2023-01-31
- Completion
- 2023-12-31
Countries
- Greece
Study Locations
More Related Trials
-
Studying Tumor Tissue Samples From Patients With Melanoma Who Have Undergone Sentinel Lymph Node Biopsy
NCT00897481 ·Status: UNKNOWN
-
A Model for Genetic Susceptibility: Melanoma
NCT00591500 ·Status: ACTIVE_NOT_RECRUITING
-
S9431: Studying Genes and Immune Response in Tumor Samples From Patients With Locally Advanced or Metastatic Melanoma
NCT00898183 ·Status: COMPLETED
-
Biomarkers in Predicting Response to Chemotherapy in Patients With Advanced or Metastatic Melanoma Previously Treated With Carboplatin and Paclitaxel With or Without Sorafenib Tosylate
NCT01209299 ·Status: COMPLETED
-
Tumor Molecular Profiling in Patients With Prostate Cancer
NCT05573789 ·Status: COMPLETED
-
Analysis of Expression of Specific Markers in Hepatocellular Carcinoma
NCT00858000 ·Status: COMPLETED
-
Analysis of Molecular Biomarkers in Periocular Adnexal Tumours
NCT06080009 ·Status: RECRUITING ·Phase: NA
-
The Registry Study of Genetic Alterations of Melanoma in Taiwan
NCT06952400 ·Status: RECRUITING
-
The Role of Genetic Mutations and of Circulating mRNAs in Uveal Melanoma
NCT05179174 ·Status: UNKNOWN
-
HNSCC Immuno-genomics Project
NCT06725342 ·Status: COMPLETED
-
The Identification of Novel Prognostic Markers in Melanoma
NCT01002560 ·Status: UNKNOWN
-
Differences in Trends Malignant Germ Cell Tumors in Males and Females: A SEER Population-based Study
NCT00322790 ·Status: WITHDRAWN
-
Studying Genes to Identify Melanoma in Patients in Iceland and Their Family Members
NCT00346008 ·Status: COMPLETED
-
Molecular Profiling in Prostate Cancer
NCT04983628 ·Status: UNKNOWN
-
Reflectance Confocal Microscopy and Molecular Correlation in Atypical Melanocytic Lesions
NCT07277920 ·Status: RECRUITING
-
The Study Aims to Measure the Metabolome in Melanoma Patients Using NMR Spectroscopy and Gas Chromatography and to Analyse Differences Depending on the Course of the Disease.
NCT06765850 ·Status: RECRUITING
-
Differential Risks for Melanoma: p16 and DNA Repair
NCT00615095 ·Status: COMPLETED
-
Clinical Value of Molecular Genetic Analyzes in Gynecological Malignomas
NCT03194347 ·Status: COMPLETED
-
Expression Analysis of Specific Markers in Non-small Cell Lung Cancer or Melanoma
NCT00685750 ·Status: TERMINATED ·Phase: NA
-
Interest and Impact of Skin Cancer Genetic Testing
NCT02941900 ·Status: COMPLETED
-
Leveraging ctDNA Analysis to Improve Early Detection of Cancer Recurrence in the High-Risk Melanoma Setting
NCT05079113 ·Status: COMPLETED
-
Tissue Microarrays (TMAs) Construction in Lung Cancer Samples
NCT03136523 ·Status: COMPLETED
-
ctDNA in Cutaneous Squamous Cell Carcinoma
NCT06875609 ·Status: RECRUITING
-
Targeted Next-generation Sequencing Panel for Identification of Germline Mutations in Early Onset Cancers With Sporadic or Hereditary Presentation
NCT02664389 ·Status: TERMINATED ·Phase: NA
-
Circulating Cell-free DNA in Metastatic Melanoma Patient: Mutational Analyses in Consecutive Measurement Before and After Chemotherapy
NCT02133222 ·Status: COMPLETED ·Phase: NA